Evidence map›Paper›PMID 36523665›Full record

ArticleCureus2022

Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report.

Jose D Roman

Abstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jose D RomanGynaecology Department, Braemar Hospital, Hamilton, NZL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intrauterine device (IUD) is the most popular method of reversible contraception in women of reproductive age nowadays, and its use is being reported by nearly 160 million women. It is considered safe and effective, but intrauterine devices are associated with rare complications such as uterine perforation. We report a case of uterine perforation by a levonorgestrel-releasing intrauterine device (LNG-IUD), Mirena (Bayer, Auckland, New Zealand) levonorgestrel 52 mg, to create awareness of the diagnosis and the laparoscopic management of these rare cases.

Indexed as

complications of iuddiagnosis of uterine perforation by iudlevonorgestrel-releasing intrauterine devicemanagement of uterine perforation by iuduterine perforation by intrauterine device

Identifiers

PMID36523665
PMCPMC9744392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.